Abstract
Abstract
Purpose
Lower-extremity lymphedema (LEL) is a lifelong consequence of cancer therapy and can lead to serious physical and psychosocial complications for many cancer survivors. However, clinical knowledge and treatment of LEL remain minimal. The purpose of this study was to integrate perspectives of lymphedema patients and healthcare providers (HCPs) on LEL to develop a novel model for quality lymphedema care.
Methods
A mixed-methods approach was implemented. Standardized questionnaires and semi-structured interviews were used to assess psychosocial well-being and experiences of LEL patients. Interviews were also used to evaluate the clinical experiences of HCPs working within tumour groups associated with cancer-related LEL. Thematic analysis was used to analyse qualitative data.
Results
Twenty-two patients and eleven HCPs participated in this study. Patient QOL, generalized anxiety and depressive symptom scores revealed a complex interplay between psychosocial well-being and supportive LEL care after cancer. Three themes emerged from interviews with patients (n = 19) and HCPs (n = 11): level of lymphedema knowledge, effectiveness of rehabilitation oncology services and barriers to care.
Implications for Cancer Survivors
We developed a novel model for quality lymphedema care that emphasizes the importance of continued physical and psychosocial support for LEL patients, while illustrating the importance of HCPs in facilitating a smooth transition for patients to LEL care after cancer treatment.
Funder
Enbridge Research Chair in Psychosocial Oncology
Training in Research and Clinical Trials in Integrative Oncology (TRACTION) Fellowship
Cumming School of Medicine-Charbonneau Cancer Institute Postdoctoral Fellowship
Alberta Cancer Foundation
Canadian Cancer Society Alberta/Northwest Territories Division
Canadian Institutes of Health Research Mentorship Chair in Innovative Clinical Trials
Publisher
Springer Science and Business Media LLC
Subject
Oncology(nursing),Oncology
Reference42 articles.
1. Greene AK. Epidemiology and Morbidity of Lymphedema. In: Greene A, Slavin S, Brorson H, editors. Lymphedema. 1st ed. Switzerland: Springer International Publishing; 2015. p. 3–345.
2. Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. J Pyschological, Soc Behav Dimens Cancer. 2013;1484:1466–84.
3. Loprinzi PD, Cardinal BJ, Winters-stone K, Smit E, Loprinzi CL. Physical activity and the risk of breast cancer recurrence: a literature review. Oncol Nurs Forum. 2012;39(3):269–74.
4. Sharma A, Schwartz R. Stewart-Treves syndrome: pathogenesis and management. J Am Dermatology. 2012;67(6):1342–8. https://doi.org/10.1016/j.jaad.2012.04.028.
5. Ryan M, Hons BN, Stainton MC, Jaconelli C, Nurs D, Medsurgnurs G, et al. The experience of lower limb lymphedema for women after treatment for gynecologic cancer. Oncol Nurs Forum. 2003;30(3):417–23.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献